142 related articles for article (PubMed ID: 24970600)
1. Overexpression of Yin Yang 1 in bone marrow-derived human multiple myeloma and its clinical significance.
Huerta-Yepez S; Liu H; Baritaki S; Del Lourdes Cebrera-Muñoz M; Rivera-Pazos C; Maldonado-Valenzuela A; Valencia-Hipolito A; Vega MI; Chen H; Berenson JR; Bonavida B
Int J Oncol; 2014 Sep; 45(3):1184-92. PubMed ID: 24970600
[TBL] [Abstract][Full Text] [Related]
2. Expression of transcription factor Yin Yang 1 in prostate cancer.
Seligson D; Horvath S; Huerta-Yepez S; Hanna S; Garban H; Roberts A; Shi T; Liu X; Chia D; Goodglick L; Bonavida B
Int J Oncol; 2005 Jul; 27(1):131-41. PubMed ID: 15942652
[TBL] [Abstract][Full Text] [Related]
3. HIF-1α of bone marrow endothelial cells implies relapse and drug resistance in patients with multiple myeloma and may act as a therapeutic target.
Ria R; Catacchio I; Berardi S; De Luisi A; Caivano A; Piccoli C; Ruggieri V; Frassanito MA; Ribatti D; Nico B; Annese T; Ruggieri S; Guarini A; Minoia C; Ditonno P; Angelucci E; Derudas D; Moschetta M; Dammacco F; Vacca A
Clin Cancer Res; 2014 Feb; 20(4):847-58. PubMed ID: 24297864
[TBL] [Abstract][Full Text] [Related]
4. Contribution of either YY1 or BclXL-induced inhibition by the NO-donor DETANONOate in the reversal of drug resistance, both in vitro and in vivo. YY1 and BclXL are overexpressed in prostate cancer.
Huerta-Yepez S; Baritaki S; Baay-Guzman G; Hernandez-Luna MA; Hernandez-Cueto A; Vega MI; Bonavida B
Nitric Oxide; 2013 Feb; 29():17-24. PubMed ID: 23246440
[TBL] [Abstract][Full Text] [Related]
5. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
Huerta-Yepez S; Vega M; Garban H; Bonavida B
Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-6 signaling with CNTO 328 enhances the activity of bortezomib in preclinical models of multiple myeloma.
Voorhees PM; Chen Q; Kuhn DJ; Small GW; Hunsucker SA; Strader JS; Corringham RE; Zaki MH; Nemeth JA; Orlowski RZ
Clin Cancer Res; 2007 Nov; 13(21):6469-78. PubMed ID: 17975159
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of YY1 protein expression and mRNA levels by bioinformatics analysis in human cancers: a therapeutic target.
Bonavida B; Kaufhold S
Pharmacol Ther; 2015 Jun; 150():149-68. PubMed ID: 25619146
[TBL] [Abstract][Full Text] [Related]
8. Bortezomib overcomes cell-adhesion-mediated drug resistance through downregulation of VLA-4 expression in multiple myeloma.
Noborio-Hatano K; Kikuchi J; Takatoku M; Shimizu R; Wada T; Ueda M; Nobuyoshi M; Oh I; Sato K; Suzuki T; Ozaki K; Mori M; Nagai T; Muroi K; Kano Y; Furukawa Y; Ozawa K
Oncogene; 2009 Jan; 28(2):231-42. PubMed ID: 18850009
[TBL] [Abstract][Full Text] [Related]
9. Role of the Transcription Factor Yin Yang 1 and Its Selectively Identified Target Survivin in High-Grade B-Cells Non-Hodgkin Lymphomas: Potential Diagnostic and Therapeutic Targets.
Vivarelli S; Falzone L; Ligresti G; Candido S; Garozzo A; Magro GG; Bonavida B; Libra M
Int J Mol Sci; 2020 Sep; 21(17):. PubMed ID: 32899428
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib resistance in a myeloma cell line is associated to PSMβ5 overexpression and polyploidy.
Balsas P; Galán-Malo P; Marzo I; Naval J
Leuk Res; 2012 Feb; 36(2):212-8. PubMed ID: 21978467
[TBL] [Abstract][Full Text] [Related]
11. Effect of noncompetitive proteasome inhibition on bortezomib resistance.
Li X; Wood TE; Sprangers R; Jansen G; Franke NE; Mao X; Wang X; Zhang Y; Verbrugge SE; Adomat H; Li ZH; Trudel S; Chen C; Religa TL; Jamal N; Messner H; Cloos J; Rose DR; Navon A; Guns E; Batey RA; Kay LE; Schimmer AD
J Natl Cancer Inst; 2010 Jul; 102(14):1069-82. PubMed ID: 20505154
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor YY1 expression in human gastrointestinal cancer cells.
Chinnappan D; Xiao D; Ratnasari A; Andry C; King TC; Weber HC
Int J Oncol; 2009 May; 34(5):1417-23. PubMed ID: 19360355
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of the transcription factor Yin Yang 1 activity by S-nitrosation.
Hongo F; Garban H; Huerta-Yepez S; Vega M; Jazirehi AR; Mizutani Y; Miki T; Bonavida B
Biochem Biophys Res Commun; 2005 Oct; 336(2):692-701. PubMed ID: 16143308
[TBL] [Abstract][Full Text] [Related]
14. Frequent alteration of the Yin Yang 1/Raf-1 kinase inhibitory protein ratio in hepatocellular carcinoma.
Notarbartolo M; Giannitrapani L; Vivona N; Poma P; Labbozzetta M; Florena AM; Porcasi R; Muggeo VM; Sandonato L; Cervello M; Montalto G; D'Alessandro N
OMICS; 2011 May; 15(5):267-72. PubMed ID: 21332389
[TBL] [Abstract][Full Text] [Related]
15. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
Pei XY; Dai Y; Grant S
Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
[TBL] [Abstract][Full Text] [Related]
16. microRNA-7 is a novel inhibitor of YY1 contributing to colorectal tumorigenesis.
Zhang N; Li X; Wu CW; Dong Y; Cai M; Mok MT; Wang H; Chen J; Ng SS; Chen M; Sung JJ; Yu J
Oncogene; 2013 Oct; 32(42):5078-88. PubMed ID: 23208495
[TBL] [Abstract][Full Text] [Related]
17. Photoreceptor-specific expression, light-dependent localization, and transcriptional targets of the zinc-finger protein Yin Yang 1 in the chicken retina.
Bernard M; Voisin P
J Neurochem; 2008 May; 105(3):595-604. PubMed ID: 18047560
[TBL] [Abstract][Full Text] [Related]
18. Expression of transcription factor Yin Yang 1 in human osteosarcomas.
de Nigris F; Botti C; de Chiara A; Rossiello R; Apice G; Fazioli F; Fiorito C; Sica V; Napoli C
Eur J Cancer; 2006 Oct; 42(15):2420-4. PubMed ID: 16962318
[TBL] [Abstract][Full Text] [Related]
19. Bortezomib-resistant myeloma cell lines: a role for mutated PSMB5 in preventing the accumulation of unfolded proteins and fatal ER stress.
Ri M; Iida S; Nakashima T; Miyazaki H; Mori F; Ito A; Inagaki A; Kusumoto S; Ishida T; Komatsu H; Shiotsu Y; Ueda R
Leukemia; 2010 Aug; 24(8):1506-12. PubMed ID: 20555361
[TBL] [Abstract][Full Text] [Related]
20. The involvement of the transcription factor Yin Yang 1 in cancer development and progression.
Castellano G; Torrisi E; Ligresti G; Malaponte G; Militello L; Russo AE; McCubrey JA; Canevari S; Libra M
Cell Cycle; 2009 May; 8(9):1367-72. PubMed ID: 19342874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
